Less chemotherapy, more personalized care: Study reinforces major strides in geriatric oncology
Experimental drug boosts immunotherapy effectiveness in pancreatic cancer in mice
4 November 2021Enhanced therapeutic foods improve cognition in malnourished children
4 November 2021Less chemotherapy, more personalized care: Study reinforces major strides in geriatric oncology
Doctors can safely lower the dose of cancer treatment such as chemotherapy without impacting survival for adults older than 70 who are at high risk for toxic side effects. The results are from a potentially practice-changing new study, published in The Lancet, and led by a Wilmot Cancer Institute scientist at the University of Rochester Medical Center.
